# Khalil El Karoui

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/khalil-el-karoui/

## Facts

| Field | Value |
| --- | --- |
| Citations | 3,670 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 32 |
| i10-index | 51 |
| Last Known Institution | Inserm |
| OpenAlex ID | https://openalex.org/A5088819374 |
| ORCID iD | 0000-0002-2978-6698 |
| Works | 134 |

## Researcher papers

- [Lipocalin 2 is essential for chronic kidney disease progression in mice and humans](https://scholariq.org/papers/lipocalin-2-is-essential-for-chronic-kidney-disease-progression-in-mice-and/)
- [Anti-CTLA4 Antibody–Induced Lupus Nephritis](https://scholariq.org/papers/anti-ctla4-antibody-induced-lupus-nephritis/)
- [Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database](https://scholariq.org/papers/adverse-events-associated-with-jak-inhibitors-in-126-815-reports-from-the-who/)
- [COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment](https://scholariq.org/papers/covid-19-in-dialysis-clinical-impact-immune-response-prevention-and-treatment/)
- [A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy](https://scholariq.org/papers/a-clinicopathologic-study-of-thrombotic-microangiopathy-in-iga-nephropathy/)
- [Low incidence of SARS-CoV-2, risk factors of mortality and the course of illness in the French national cohort of dialysis patients](https://scholariq.org/papers/low-incidence-of-sars-cov-2-risk-factors-of-mortality-and-the-course-of-illness/)
- [Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease](https://scholariq.org/papers/bortezomib-produces-high-hematological-response-rates-with-prolonged-renal/)
- [Focal segmental glomerulosclerosis plays a major role in the progression of IgA nephropathy. II. Light microscopic and clinical studies](https://scholariq.org/papers/focal-segmental-glomerulosclerosis-plays-a-major-role-in-the-progression-of-iga/)
- [Use of Highly Individualized Complement Blockade Has Revolutionized Clinical Outcomes after Kidney Transplantation and Renal Epidemiology of Atypical Hemolytic Uremic Syndrome](https://scholariq.org/papers/use-of-highly-individualized-complement-blockade-has-revolutionized-clinical/)
- [Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2](https://scholariq.org/papers/endoplasmic-reticulum-stress-drives-proteinuria-induced-kidney-lesions-via/)
- [Treatment of IgA Nephropathy: A Rapidly Evolving Field](https://scholariq.org/papers/treatment-of-iga-nephropathy-a-rapidly-evolving-field/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [COVID-19 Clinical Research Studies](https://scholariq.org/topics/covid-19-clinical-research-studies/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Autoimmune Bullous Skin Diseases](https://scholariq.org/topics/autoimmune-bullous-skin-diseases/)

## Researcher university

- [Inserm](https://scholariq.org/institutions/inserm/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.